中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
2期
147-149
,共3页
多囊卵巢综合征%不孕%体外受精-胚胎移植
多囊卵巢綜閤徵%不孕%體外受精-胚胎移植
다낭란소종합정%불잉%체외수정-배태이식
Polycystic ovary syndrome%Infertility%In vitro fertilization and embryo transfer
目的：探讨多囊卵巢综合征（PCOS）伴不孕患者采用体外受精-胚胎移植（IVF-ET）助孕治疗的疗效及特点。方法：回顾分析2013年52周期PCOS不孕因素IVF-ET病历资料作为A组，同期102周期输卵管因素IVF-ET病例作对照作为B组。结果：PCOS组与输卵管因素组比较分析：患者年龄、不孕年限、BMI、Gn天数、获卵数、可移植胚胎数、OHSS风险取消移植率比较，差异有统计学意义（P<0.05）。PCOS组患者较输卵管因素组更年轻，不孕时间短、体重指数高，Gn时间长，获卵数多，相应可移植胚胎多，OHSS风险明显升高。而两组Gn用量、内膜厚度、2PN受精率、卵裂率、优胚率及临床妊娠率等差异均无统计学意义（P>0.05）。结论：PCOS伴不孕患者采用IVF-ET助孕可获得与输卵管因素IVF-ET助孕相似的疗效，但要注意OHSS的风险预防。
目的：探討多囊卵巢綜閤徵（PCOS）伴不孕患者採用體外受精-胚胎移植（IVF-ET）助孕治療的療效及特點。方法：迴顧分析2013年52週期PCOS不孕因素IVF-ET病歷資料作為A組，同期102週期輸卵管因素IVF-ET病例作對照作為B組。結果：PCOS組與輸卵管因素組比較分析：患者年齡、不孕年限、BMI、Gn天數、穫卵數、可移植胚胎數、OHSS風險取消移植率比較，差異有統計學意義（P<0.05）。PCOS組患者較輸卵管因素組更年輕，不孕時間短、體重指數高，Gn時間長，穫卵數多，相應可移植胚胎多，OHSS風險明顯升高。而兩組Gn用量、內膜厚度、2PN受精率、卵裂率、優胚率及臨床妊娠率等差異均無統計學意義（P>0.05）。結論：PCOS伴不孕患者採用IVF-ET助孕可穫得與輸卵管因素IVF-ET助孕相似的療效，但要註意OHSS的風險預防。
목적：탐토다낭란소종합정（PCOS）반불잉환자채용체외수정-배태이식（IVF-ET）조잉치료적료효급특점。방법：회고분석2013년52주기PCOS불잉인소IVF-ET병력자료작위A조，동기102주기수란관인소IVF-ET병례작대조작위B조。결과：PCOS조여수란관인소조비교분석：환자년령、불잉년한、BMI、Gn천수、획란수、가이식배태수、OHSS풍험취소이식솔비교，차이유통계학의의（P<0.05）。PCOS조환자교수란관인소조경년경，불잉시간단、체중지수고，Gn시간장，획란수다，상응가이식배태다，OHSS풍험명현승고。이량조Gn용량、내막후도、2PN수정솔、란렬솔、우배솔급림상임신솔등차이균무통계학의의（P>0.05）。결론：PCOS반불잉환자채용IVF-ET조잉가획득여수란관인소IVF-ET조잉상사적료효，단요주의OHSS적풍험예방。
Objective:To evaluate the polycystic ovary syndrome (PCOS) with infertility were treated by in vitro fertilization-embryo transfer (IVF-ET) curative effect and characteristics of assisted reproduction treatment. Method: 52 cycles PCOS infertility factor in IVF-ET medical records in 2013 year were analysed retrospectively as group A, and 102 cycles tubal factor IVF-ET cases in the same period as controls of group B.Result:Compared PCOS group and tubal factor group analysis: age, infertility time, BMI, the number of eggs, portable designed the Gn days, embryo number and risk of OHSS cancel graft rate comparison, the difference was statistically significant(P<0.05). PCOS patients compared with tubal factor group more young, shorter infertility time, higher body mass index (BMI),longer Gn time,more egg number, more corresponding portable embryos and OHSS risk increased significantly. But two groups of designed the Gn dosage, endometrium thickness, 2 PN fertilization rate, cleavage rate, good embryo rate and the clinical pregnancy rate were no statistically significant difference.Conclusion:PCOS patients of infertility with the IVF-ET assist reproduction can be obtained IVF-ET assist similar curative effect with the tubal factor, but should pay attention to prevent the risk of OHSS.
